Turing Chief executive officer Shkreli has said he would likely role back the price spike in call “to the rage that is what undergone by certain people”, but hasn’t stated what your new price will be.
Advertisement
Over a pair of responses to drug-related questions, Clinton touted her recently unveiled prescription drug cost plan, which includes a proposal to cap monthly and annual out-of-pocket health costs and to speed up the approval of generic drugs.
The same day, Clinton accused Shrekli of “price gouging” on Twitter, and teased her own plan to limit prescription drug prices that she would release the next day.
Hillary Clinton will never stop this fight because Turing Pharmaceuticals isn’t the only company charging outrageous skyrocketing prices for prescription drugs that put them out of reach for everyday Americas who need them to get healthy or stay well. So Mr. Shkreli, what’s it going to be?
Turing, a pharmaceutical startup that Shkreli founded in February, bought the United States marketing rights to the drug Daraprim in August.
The drug is the only FDA-approved treatment for toxoplasmosis, a parasitic disease that can prove deadly, especially to those with compromised immune systems, such as those with AIDs, cancer or who are pregnant.
The new 30-second spot is part of the campaign’s ongoing buy in Iowa and New Hampshire and will run alongside previously released ads.
The ad also features a Fox News commentator saying the former hedge fund manager, Martin Shkreli “may be lowering” the price “after Hillary Clinton blasted him out of the water”.
Advertisement
While Shkreli told several media outlets Tuesday night that the company will reconsider the price hike, he did not specify what the drug’s new cost will be. Do the right thing.
